跳至主要内容
临床试验/ACTRN12612001299897
ACTRN12612001299897尚未招募未知

Monitoring the Quantitative HBsAg Levels in Guiding the Efficacy of Chronic Hepatitis B Therapies

Gastroenterology Institute of Marmara University0 个研究点目标入组 100 人开始时间: 2012年12月17日最近更新:

试验速览

阶段
未知
状态
尚未招募
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • Treatment-naive-hepatitis B virus infection patients for whom a treatment plan has been made by the hepatology outpatient clinic. (Indication for treatment is the presence of HBs Ag in serum for more than 6 months, and by liver biopsy showing histological features of chronic hepatitis compatible with HBV infection.)

排除标准

  • - Prior antiviral therapy
  • - Immunosuppressive therapy within the previous 6 months
  • - Presence of viral coinfections,with hepatitis C, hepatitis D, or human immunodeficiency virus;
  • - Presence of other acquired or inherited causes of liver disease

研究者

发起方
Gastroenterology Institute of Marmara University

相似试验